Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

Korea Arlico Pharm Revenue

Korea Arlico Pharm had revenue of 50.30B KRW in the quarter ending June 30, 2025, with 11.95% growth. This brings the company's revenue in the last twelve months to 201.83B, up 12.86% year-over-year. In the year 2024, Korea Arlico Pharm had annual revenue of 190.44B with 1.75% growth.

• Revenue (ttm): 201.83B
• Revenue Growth: +12.86%
• P/S Ratio: 0.28
• Revenue / Employee: 1.80B
• Employees: 112
• Market Cap: 57.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	190.44B	3.28B	1.75%
Dec 31, 2023	187.15B	19.42B	11.58%
Dec 31, 2022	167.74B	27.58B	19.68%
Dec 31, 2021	140.16B	15.35B	12.30%
Dec 31, 2020	124.81B	9.02B	7.79%